{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:09:49Z","timestamp":1790766589529,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ygyno.2022.05.024","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:58:56Z","timestamp":1655441936000},"page":"254-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer"],"prefix":"10.1016","volume":"166","author":[{"given":"Rachel","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.J.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeh Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Berton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia T.","family":"Roncolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel O.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikou","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit M.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Avall-Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Berek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lanceley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hilpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Diamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.05.024_bb0005","first-page":"161","article-title":"Carcinoma of the ovary. FIGO 26th annnual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.ygyno.2022.05.024_bb0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/IGC.0000000000000147","article-title":"Symptom burden and outcomes of patients with platinum resistant\/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study","volume":"24","author":"Friedlander","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2022.05.024_bb0015","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1111\/IGC.0b013e3181bf7fb8","article-title":"Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory\/resistant ovarian cancer","volume":"19","author":"Friedlander","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2022.05.024_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ygyno.2016.08.235","article-title":"Symptom management in women with recurrent ovarian cancer: do patients and clinicians agree on what symptoms are most important?","volume":"143","author":"Hay","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.05.024_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0000000000000167","article-title":"Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer","volume":"24","author":"King","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.05.024_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 consensus statements on the management of ovarian cancer: final document of the 3rd international gynecologic cancer intergroup ovarian cancer consensus conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.05.024_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11136-017-1729-8","article-title":"Measuring what matters MOST: validation of the measure of ovarian symptoms and treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer","volume":"27","author":"King","year":"2018","journal-title":"QOLR"},{"issue":"3","key":"10.1016\/j.ygyno.2022.05.024_bb0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1200\/JCO.1994.12.3.608","article-title":"Lessons learned from measuring health-related quality of life in oncology","volume":"12","author":"Osoba","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.05.024_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ygyno.2022.05.024_bb0055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0959-8049(03)00307-1","article-title":"An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer","volume":"39","author":"Greimel","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2022.05.024_bb0060","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","article-title":"Reliability and validity of the functional assessment of cancer therapy-ovarian","volume":"19","author":"Basen-Engquist","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.05.024_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010938","article-title":"Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review","volume":"6","author":"Mercieca-Bebber","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ygyno.2022.05.024_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2022.05.024_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00451727","article-title":"Psychometric properties and responsiveness of the EORTC quality of life questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer","volume":"3","author":"Osoba","year":"1994","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.ygyno.2022.05.024_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct. Equ. Model. Multidiscip. J."},{"key":"10.1016\/j.ygyno.2022.05.024_bb0085","series-title":"Methodology in the Social Sciences","article-title":"Principles and practice of structural equation modeling","author":"Kline","year":"2015"},{"issue":"9","key":"10.1016\/j.ygyno.2022.05.024_bb0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1634\/theoncologist.2017-0047","article-title":"Reducing uncertainty: predictors of stopping chemotherapy early and shortened survival time in platinum resistant\/refractory ovarian cancer-the GCIG symptom benefit study","volume":"22","author":"Roncolato","year":"2017","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ygyno.2022.05.024_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw253","article-title":"Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations","volume":"109","author":"Miaskowski","year":"2017","journal-title":"JNCI"},{"issue":"8","key":"10.1016\/j.ygyno.2022.05.024_bb0100","first-page":"831","article-title":"Symptom clustering in advanced cancer","volume":"14","author":"Walsh","year":"2006","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2022.05.024_bb0105","first-page":"573","article-title":"Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review","volume":"29","author":"Graupner","year":"2021","journal-title":"Support Care Cancer"},{"issue":"13","key":"10.1016\/j.ygyno.2022.05.024_bb0110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1200\/JCO.21.00656","article-title":"Effects of the WRITE symptoms interventions on symptoms and quality of life among patients with recurrent ovarian cancers: an NRG oncology\/GOG study (GOG-0259)","volume":"40","author":"Donovan","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2022.05.024_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2017.07.004","article-title":"Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy","volume":"216","author":"Wen","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.05.024_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007618","article-title":"Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates","volume":"5","author":"Watts","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ygyno.2022.05.024_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pon.897","article-title":"Clinical practice guidelines for the psychosocial care of adults with cancer","volume":"14","author":"Turner","year":"2005","journal-title":"Psycho-Oncology"},{"issue":"2","key":"10.1016\/j.ygyno.2022.05.024_bb0130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2021.08.022","article-title":"Development and validation of the measure of ovarian symptoms and treatment concerns for surveillance (MOST-S26): an instrument to complement the clinical follow-up of women with ovarian cancer after completion of first-line treatment","volume":"163","author":"Campbell","year":"2021","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822003353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822003353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:59Z","timestamp":1758772799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822003353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0090825822003353"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.05.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}